Intra-articular drain position versus subfascial drain position in autologous blood retransfusion in total hip arthroplasty

Phase 3

Recruiting

• Conditions: wondbloed productie; postoperative anemia

• Registration Number: NL-OMON31269
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients sceduled for elective total hip arthroplasty and treated with postoperative retransfusion system

Exclusion Criteria

Patients with already threated anemia, any active infection, current malignancy, uncontrolled hypertension, operated in 3 weeks before randomisation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the amount of shed blood used for autologous<br /><br>retransfusion. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary parameters are perioperative hemoglobine levels and the amount of<br /><br>allogeneic blood transfusions. </p><br>